Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins - Wikidata - wikimedia - TriplyDB

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins

http://www.wikidata.org/entity/Q28469068

about

Acinetobacter baumannii: an emerging opportunistic pathogen Monoclonal antibody-based therapies for microbial diseases A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitro Pre-clinical evaluation of a 213Bi-labeled 2556 antibody to HIV-1 gp41 glycoprotein in HIV-1 mouse models as a reagent for HIV eradication Treating cancer as an infectious disease--viral antigens as novel targets for treatment and potential prevention of tumors of viral etiology Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs The potential of radioimmunotherapy as a new hope for HIV patients.Inhibition of in vivo HIV infection in humanized mice by gene therapy of human hematopoietic stem cells with a lentiviral vector encoding a broadly neutralizing anti-HIV antibody.Systemic targeted alpha radiotherapy for cancer.Radioimmunotherapy with α-particle-emitting radionuclides.Radiolabeled antibodies for therapy of infectious diseases.Cryptococcus neoformans as a Model for Radioimmunotherapy of Infections Eradicating HIV-1 infection: seeking to clear a persistent pathogen.Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques.Targeted cytotoxic therapy: adapting a rapidly progressing anticancer paradigm for depletion of persistent HIV-infected cell reservoirs.Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory act A fully human antibody to gp41 selectively eliminates HIV-infected cells that transmigrated across a model human blood brain barrier Potential of Radiation-Induced Cellular Stress for Reactivation of Latent HIV-1 and Killing of Infected Cells Radioimmunotherapy of infectious diseases Combination of Antiretroviral Drugs and Radioimmunotherapy Specifically Kills Infected Cells from HIV-Infected Individuals.Radiolabeled antibodies to Bacillus anthracis toxins are bactericidal and partially therapeutic in experimental murine anthrax.Radioimmunotherapy of fungal diseases: the therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens.Curing HIV: lessons from cancer therapy Breaking the mould - novel diagnostic and therapeutic strategies for invasive pulmonary aspergillosis in the immune deficient patient.Role of nuclear medicine in neuroHIV: PET, SPECT, and beyond.Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activity.Radioimmunotherapy of infection with Bi-labeled antibodies Targeted alpha-therapy using [Bi-213]anti-CD20 as novel treatment option for radio- and chemoresistant non-Hodgkin lymphoma cells.Radioimmunotherapy is effective against high-inoculum Cryptococcus neoformans infection in mice and does not select for radiation-resistant cryptococcal cells.Targeting host cells harbouring viruses with radiolabeled antibodies.

P2860

Q26830893-A7A09909-5848-47CF-8135-96665EF8F526 Q27490830-E38352B4-E24B-4919-B92F-01DF3FD5A708 Q28728917-87CDE2DD-12BA-4120-ABA7-670206466B28 Q28731318-3C28841A-51FF-4DA2-A281-EBD8BB7C864E Q33304454-7B0E0CF8-0B9C-4161-B5E0-730E0AB6A888 Q33604776-10AC5377-5F3E-4E3D-BCA6-6B3091705D20 Q33863509-84CC2984-97A9-43E3-A851-52DBC57AB2BE Q33990484-E9ABC7F2-29B7-4EE9-A297-889A14D996D8 Q34377594-490A5884-5B8A-401B-B718-FD64D7803063 Q34419562-B5A1BB39-04ED-468E-943A-31CF87CB3CF8 Q34955947-75498750-95E2-4EF5-9AEF-A6D2BC446DB5 Q35072954-F94B4D97-8B74-4A0B-B221-00B81C704835 Q35252186-EE04A5A1-1A05-40D7-9DCB-A4E1A08BAB62 Q35586914-3A8D6EE5-E9BB-4AE7-9D23-CF9479A40530 Q36073562-A2C8C0E2-069B-4EFA-B835-06E6394D8A8C Q36206925-84FEDF39-504F-486E-BE88-DC32A3D9B436 Q36484055-9A85AF2A-566A-4ADA-A84C-872DCDC83AF8 Q36522639-50F85335-5BB7-49EC-94E3-C46A9A079E23 Q36601890-FEFCFFA8-DD9D-4EA0-9BE6-9F56CB587917 Q37178873-146DA3CE-B614-41D6-9AE7-6793DC3EEE83 Q37281138-1D6E9331-61C0-4CA5-B0F3-61402B09BE88 Q37409957-FB54AA1B-557E-4D5E-A6E5-E4A73B7ECB18 Q37978622-487A3C03-833B-4C21-93CA-FFDF79FA1706 Q38085989-02FA6F06-2352-4DFB-A9CC-EA6E2E95F0EC Q38201109-7150FE84-7018-426F-AE3E-8F0EDDE584F9 Q38208168-FFC61C1B-7611-481D-A5C6-9F29F4F1634D Q39394353-CBE1F937-CF97-4D4C-BBB3-3165169E72AB Q39557992-0E453041-0C3A-4E51-82A8-17FA07BBD710 Q42077750-B17AB7E8-ABCF-4752-8A73-2E408616171A Q43153507-801C8E53-7AD6-4875-B65F-C2F0DC4F216B Q44260872-BB6A5E45-BA28-47CD-B2A0-3414674D8DF4

P2860

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins

http://www.wikidata.org/entity/Q28469068

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins

@ast

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins

@en

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins

@nl

type

label

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins

@ast

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins

@en

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins

@nl

prefLabel

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins

@ast

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins

@en

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins

@nl

P1433

Q28469068-EB924D71-3359-49CC-A77D-37BB86B36112

P1476

Q28469068-DFCAFDF4-D96C-4932-8D6C-FFD2EAD167E9

P2093

Q28469068-14E2B303-9E92-4B9A-9B38-4A44BB9C0A3D

Q28469068-29D4EF8D-8FCF-4F37-A7B0-AE72B24D90A2

Q28469068-37F52AAA-046F-4B6C-AECF-E77A17CC7924

Q28469068-3CF2820D-5F7C-4A60-B48E-0492617BC478

Q28469068-474A91C4-5798-40ED-908B-096D797D58C0

Q28469068-67DEA49A-D935-43DF-B41C-E3B5B8D431FD

Q28469068-8C032635-BBEB-40CF-A314-DF008B063A6E

Q28469068-B3063ECD-45A3-4107-A193-076217057AC0

P2860

Q28469068-06C9F948-F13F-4D70-BD0E-86049CF14D47

Q28469068-08B44D1B-B92B-4DE2-A0BA-13F2C924973E

Q28469068-0BE13DCF-CF57-4B02-90F1-797DEDEFF49B

Q28469068-0C90ADDA-D7DB-4868-9A06-D8895C59ECBB

Q28469068-0E4FFF29-8DF0-4B42-B340-C74208D17B9E

Q28469068-0EBAE931-A133-4128-A4AC-849B8252E967

Q28469068-116E2D7D-9055-46CF-9514-FF8A40C8F609

Q28469068-17E571FF-6678-4368-A6F7-5BDB352036D1

Q28469068-1CBEB545-1B7E-4BE6-9579-B59ACBE7680F

Q28469068-20A7CE4C-167C-444E-8C5E-104910015718

P304

Q28469068-B51C51B7-8647-4AEF-A106-7DFD65871F7E

P31

Q28469068-FB7D05FA-C1C3-4E72-91E9-5A9577309917

P3181

Q28469068-8E200B28-A4CA-406F-A4D7-4C724C177F48

P356

Q28469068-704283BC-DE95-49B2-BD4A-BCCF9EAFD02B

P407

Q28469068-16A6DBC4-B4D3-4DCD-8AA1-5B1D70061BE3

P433

Q28469068-AEDE0A60-BF95-4DAE-A284-024BE365DC8C

P478

Q28469068-E250ABE0-9160-431C-8272-ED45CCA5D02D

P50

Q28469068-2490638F-B1DD-4C1C-87A6-ADE32EB2D6DC

Q28469068-95F69526-8710-4F0F-AC8A-C20B7B310EE7

P577

Q28469068-36CF8B13-1582-4A9D-B478-72AC9709D858

P5875

Q28469068-9C3B6CA7-E637-4E34-A659-69ED87F7D057

P698

Q28469068-434E66E0-A8D1-4F2B-A35C-9973058EC241

P921

Q28469068-6C4F7CB0-D0A7-426C-8B1D-5565B33841AD

P932

Q28469068-FC16B54A-2B7D-43B6-98D0-172C362EC850

P3181

P356

JOURNAL.PMED.0030427

P1433

P1476

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins

@en

P2093

Alfred Morgenstern

http://www.w3.org/2001/XMLSchema#string

Christos Apostolidis

http://www.w3.org/2001/XMLSchema#string

Ekaterina Dadachova

http://www.w3.org/2001/XMLSchema#string

Harris Goldstein

http://www.w3.org/2001/XMLSchema#string

Mahesh C Patel

http://www.w3.org/2001/XMLSchema#string

Martin W Brechbiel

http://www.w3.org/2001/XMLSchema#string

Sima Toussi

http://www.w3.org/2001/XMLSchema#string

Susan Zolla-Pazner

http://www.w3.org/2001/XMLSchema#string

P2860

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

The challenge of viral reservoirs in HIV-1 infection

Antibody-targeted radiation cancer therapy

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins

Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.

Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes.

Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41

Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.

Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain.

P304

e427

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3335074

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.0030427

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Arturo Casadevall

Miroslaw K Gorny

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6707503

http://www.w3.org/2001/XMLSchema#string

P698

17090209

http://www.w3.org/2001/XMLSchema#string

P921

P932

1630718

http://www.w3.org/2001/XMLSchema#string